---
$id: https://graph.org.ai/products/commodity/51271629
$type: Product
source: UNSPSC
code: "51271629"
title: "Lidocaine hydrochloride"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lidocaine hydrochloride

**UNSPSC Code**: 51271629
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V13007Z41A. European Medicines Agency schedules Lidocaine hcl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02921MIG. Lidocaine hydrochloride generally arises in the molecular formula C14H22N2O.CLH.H2O. The term 'lidocaine hydrochloride' is an International Nomenclature of Cosmetic Ingredients designation. Most nations, for tariff and trade purposes, schedule lidocaine hydrochloride under HS 29242910 and SITC 51479. As of Q4 2014, LIDOCAINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Lidocaine hydrochloride bears US NLM identifiers UMLS ID C0546869 and NCI Concept Code C48000. SMILES: CCN(CC)CC(=O)NC1C(CCCC1C)C.O.CL.

